| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.004 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.005 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.2 | 0.006 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |